Enrichment of the Janus kinase (JAK) activation signature in severe asthma sputum: Correlation with IL-13 expression

Stelios Pavlidis (London, United Kingdom), Stelios Pavlidis, Ian Adcock, Fan Chung, Anthony Rowe, Christos Rossios, Ioannis Pandis, Ratko Djukanovich, Peter Sterk, Yike Guo, Coen Wiegman

Source: International Congress 2016 – Novel mechanisms and treatment modalities in asthma
Session: Novel mechanisms and treatment modalities in asthma
Session type: Poster Discussion
Number: 4897
Disease area: Airway diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Stelios Pavlidis (London, United Kingdom), Stelios Pavlidis, Ian Adcock, Fan Chung, Anthony Rowe, Christos Rossios, Ioannis Pandis, Ratko Djukanovich, Peter Sterk, Yike Guo, Coen Wiegman. Enrichment of the Janus kinase (JAK) activation signature in severe asthma sputum: Correlation with IL-13 expression. Eur Respir J 2016; 48: Suppl. 60, 4897

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
TNFAIP3 (A20) expression is elevated in the sputum of severe asthmatics
Source: International Congress 2016 – Novel mechanisms and treatment modalities in asthma
Year: 2016


MAPKAP kinase 2(MK2) expression is associated with severe asthma
Source: International Congress 2016 – Mechanisms of disease
Year: 2016

Altered expression of histamine receptor 4 and MAPK kinase in childhood asthma
Source: International Congress 2015 – More paediatric asthma and allergy
Year: 2015

Aerobic exercise reduces asthma phenotype by inhibition of JAK2, SOCS3 and STAT6 in airway epithelium and in peribronchial leukocytes
Source: International Congress 2016 – Latest insights into functional capacity and muscle weakness in chronic lung diseases
Year: 2016


Low power laser (LBP) therapy downregulates the allergic lung inflammation in experimental asthma model: Effect driven to signal transducer and activator of transduction 6 (STAT-6)
Source: Annual Congress 2013 –Asthma: new mechanisms and markers
Year: 2013

Systemic inhibition of p38 MAPK improves lung function and inflammatory markers in moderate-severe COPD
Source: International Congress 2015 – New data on established treatments for COPD
Year: 2015


Egr-1 regulates muc5ac expression through activator protein-1 (AP-1) in chronic airway inflammation diseases
Source: International Congress 2015 – Translational studies in airway cell biology
Year: 2015


Expression of mRNA chemokine and their receptors in nasopharingeal brush-biopsies represents age of bronchial asthma patients
Source: Annual Congress 2013 –Cell biology and murine models of asthma and inflammation
Year: 2013

The effect of the novel SHIP1 activator AQX-1125 on allergen-induced responses in mild to moderate asthma
Source: Annual Congress 2013 –New drugs in respiratory medicine
Year: 2013

Preventative administration of IL-27 improves airway inflammation of ovalbumin –induced asthma mice model via both STAT1 and GADD45γ/p38MAPK pathways
Source: International Congress 2016 – Pharmacological intervention in humans and murine models of asthma
Year: 2016


Therapeutic blockade of IL-4 and 13 signaling with dupilumab (SAR231893/REGN668) inhibits key biomarkers in asthma
Source: Annual Congress 2013 –Treatment of asthma
Year: 2013

Induced sputum lipid mediators in severe asthma
Source: International Congress 2016 – Translational studies in lung disease
Year: 2016

Synergistic effects of p38 MAPK inhibition with a corticosteroid in alveolar macrophages from corticosteroid insensitive asthma patients
Source: Annual Congress 2013 –Novel drugs for the treatment of asthma and COPD
Year: 2013

Mast cell gene signature enrichment associates with late-onset severe asthma
Source: International Congress 2016 – Phenotyping asthma
Year: 2016


Activin-A BAL levels and Immunochemistry for activin A receptors in patients with asthma
Source: International Congress 2015 – Exploring mechanisms in obstructive airway diseases
Year: 2015


Inhibition of inflammatory gene expression by dexamethasone partly depends on the phosphatase, MKP-1 (DUSP1)
Source: Annual Congress 2013 –Novel drugs and biomarkers in respiratory medicine
Year: 2013

The role of suppressor of cytokine signalling 1 (SOCS1) in virus-induced asthma exacerbations
Source: International Congress 2016 – Viral infections in different respiratory conditions: from the bedside to the lab
Year: 2016


Altered P2 receptor expression profile in sputum cells of patients with COPD
Source: International Congress 2014 – Monitoring COPD with different biomarkers
Year: 2014

The percentage of neutrophils expressing TLR4 in induced sputum decreases in asthma not eosinophilic
Source: Annual Congress 2013 –Asthma
Year: 2013


Global miRNA expression in Treg cells from patients with pulmonary sarcoidosis indicates for targeting of MAPK and FOXO signaling pathways
Source: International Congress 2015 – Latest news on miRNAs in pulmonary research
Year: 2015